0
0
12/23/22 at 1:53pm
Organization
SowetanLIVE
Author
Reuters
37 words
0
Comments
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German company announced on Friday.
You are the first to view
https://www.sowetanlive.co.za/news/africa/2022-12-23-biontech-initiates-clinical-trial-of-mrna-based-malaria-vaccine-candidate/
Create an account
or login to join the discussion